Peter G. Milner

Dr. Peter G.
Milner, MD, is a Chief Executive Officer & Director at Renexxion LLC, an Executive Chairman at Armetheon, Inc., a Chairman at AshHill Investments LLC, a Chairman & Chief Executive Officer at Renexxion Ireland Ltd. and a Chief Executive Officer at Xyra LLC.
He is on the Board of Directors at Renexxion LLC, Optivia Biotechnology, Inc., Ischemix, Inc., Lifeline Technologies, Inc. and SinuSys Corp.
Dr. Milner was previously employed as a Principal by ML Laboratories Plc, a Director, President-Research & Development by ARYx Therapeutics, Inc., a Co-Founder by CV Therapeutics, Inc., a Scientific Advisor by ABV LLC, a Chief Executive Officer & Director by Heart Metabolics Ltd., and an Assistant Professor by Washington University in St. Louis.
He also served on the board at California Healthcare Institute, Retrotope, Inc. and Stem Cell Therapeutics Corp.
He received his doctorate degree from The University of Liverpool.